hydralazine has been researched along with aspirin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (30.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldana, I; Alvarez, T; Bermejillo, MJ; Fernandez-Alvarez, E; Font, M; Latre, JA; Lopez-Unzu, MJ; Monge, A; Santiago, E | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahnfelt-Rønne, I; Arrigoni-Martelli, E | 1 |
| Bartels, T; Beitz, J; Heinemann, S; Hoffmann, P; Taube, C | 1 |
| Garcia-Marquez, F; Vidrio, H | 1 |
| Lendvay, LJ; Paolini, JP | 1 |
| Graeme, ML; John, M; Sigg, EB | 1 |
| Bambach, D; Fontana, ME; Hermiller, JB; Huss, P; Leier, CV; Magorien, RD; Thompson, MJ; Unverferth, DV | 1 |
| Kawashima, A; Koike, H; Nishio, S; Ueno, Y | 1 |
| Giles, TD | 1 |
| Agostoni, P; Alimento, M; Contini, M; Guazzi, M; Marenzi, G | 1 |
| Bednar, MM; Ellenberger, C; Gross, CE; Howard, DB; Russell, SR | 1 |
| Leavitt, K; Običan, S; Yankowitz, J | 1 |
3 review(s) available for hydralazine and aspirin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
Treatment and Prevention of Hypertensive Disorders During Pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Chronic Disease; Clonidine; Cyclooxygenase Inhibitors; Diuretics; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Maternal-Fetal Exchange; Pre-Eclampsia; Pregnancy; Pregnancy Complications | 2019 |
1 trial(s) available for hydralazine and aspirin
| Article | Year |
|---|---|
Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood-Air Barrier; Bradykinin; Cyclooxygenase Inhibitors; Diffusion; Double-Blind Method; Enalapril; Epoprostenol; Exercise Test; Female; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Alveoli; Pulmonary Circulation; Pulmonary Gas Exchange; Respiratory Function Tests | 1997 |
16 other study(ies) available for hydralazine and aspirin
| Article | Year |
|---|---|
New 5H-pyridazino[4,5-b]indole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation and inotropics.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiotonic Agents; Dinoprostone; Female; Guinea Pigs; Humans; Indoles; Platelet Aggregation Inhibitors; Pyridazines; Thromboxane A2; Thromboxane-A Synthase | 1991 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Rabbit lung microsomes: a rapid method for assaying simultaneously drug effects on thromboxane and prostacyclin synthesis.
Topics: Animals; Arachidonic Acids; Aspirin; Burimamide; Dipyridamole; Epoprostenol; Hydralazine; Imidazoles; Indomethacin; Lung; Microsomes; Prostaglandins; Rabbits; Thromboxanes | 1979 |
Cardiovascular actions of dihydralazine as modified by dietary linoleic acid.
Topics: Animals; Aorta, Abdominal; Aspirin; Blood Pressure; Dietary Fats; Dihydralazine; Epoprostenol; Fatty Acids; Female; Hydralazine; In Vitro Techniques; Indomethacin; Kidney; Linoleic Acid; Linoleic Acids; Male; Phospholipids; Pregnancy; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Species Specificity | 1986 |
The influence of cyclo-oxygenase inhibitors on the cardiovascular effects of hydralazine in rats.
Topics: Animals; Aspirin; Blood Pressure; Body Temperature; Cyclooxygenase Inhibitors; Heart Rate; Hemodynamics; Hydralazine; Indomethacin; Male; Prostaglandins; Rats; Rats, Inbred Strains; Vasodilation | 1985 |
Heterocyclic systems with a bridgehead nitrogen. II. 6-Chloroimidazo[2,1-b]thiazole and some of its 5-substituted derivatives.
Topics: Animals; Aspirin; Blood Pressure; Chemical Phenomena; Chemistry; Enterobacteriaceae; Female; Fungi; Hydralazine; Hypertension; Inflammation; Magnetic Resonance Spectroscopy; Male; Mice; Phenylbutazone; Rats; Thiazoles | 1969 |
Induction of periarthritis by oral administration of 6-sulfanilamidoindazole and its treatment in rats.
Topics: Animals; Aspirin; Chloroquine; Cloxacillin; Hydralazine; Hydrocortisone; Indomethacin; Male; Mercaptopurine; Methotrexate; Morphine; ortho-Aminobenzoates; Oxyphenbutazone; Paramethasone; Periarthritis; Phenylbutazone; Rats; Sulfinpyrazone; Sulfonamides | 1967 |
Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
Topics: Adolescent; Adult; Aspirin; Diazoxide; Dipyridamole; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Indomethacin; Isoproterenol; Isosorbide Dinitrate; Middle Aged; Phentolamine; Prostaglandin Antagonists; Tolazoline; Vascular Resistance; Vasodilator Agents | 1982 |
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Topics: Administration, Oral; Alprostadil; Animals; Aspirin; Bridged Bicyclo Compounds; Collagen; Diltiazem; Drug Evaluation, Preclinical; Epinephrine; Epoprostenol; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Heparin; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Mice; Nifedipine; Nitroprusside; Platelet Aggregation Inhibitors; Pulmonary Embolism; Superoxide Dismutase; Vasodilator Agents | 1995 |
The effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis.
Topics: Animals; Antihypertensive Agents; Aspirin; Atenolol; Brain Ischemia; Cerebrovascular Circulation; Drug Interactions; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hydralazine; Male; Nitric Oxide; Nitric Oxide Donors; Prostaglandins, Synthetic; Rabbits; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vasodilator Agents | 2001 |